Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis
- PMID: 27031503
- PMCID: PMC4816324
- DOI: 10.1371/journal.pone.0151607
Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis
Abstract
Objectives: To compare the prevalence of prothrombin G20210A in patients with objectively confirmed cerebral vein or cortical vein thrombosis against healthy controls, and evaluate geographical variations.
Design: Systematic review and meta-analysis of case control studies.
Methods: We conducted a systematic review of electronic databases including MEDLINE and EMBASE. The main outcome was the prevalence of prothrombin G20210A in patients with objectively confirmed cerebral vein or cortical vein thrombosis; we also analyzed individual country variations in the prevalence. The random-effects model OR was used as the primary outcome measure.
Results: In total 19 studies evaluated 868 cases of cerebral venous thrombosis and 3981 controls. Prothrombin G20210A was found in 103/868 of the patients with cerebral venous thrombosis and 105/3999 of the healthy controls [random effects pooled OR 5.838, 95% CI 3.96 to 8.58; I217.9%]. The prevalence of prothrombin G20210A was significantly elevated in Italian studies (OR 9.69), in Brazilian studies (OR 7.02), and in German studies (OR 3.77), but not in Iranian studies (OR 0.98).
Conclusion: Prothrombin G20210A is significantly associated with cerebral venous thrombosis when compared to healthy controls, although this association is highly dependent on the country of origin.
Conflict of interest statement
Figures
Similar articles
-
Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis.Eur J Vasc Endovasc Surg. 2015 Aug;50(2):232-40. doi: 10.1016/j.ejvs.2015.04.033. Epub 2015 Jun 16. Eur J Vasc Endovasc Surg. 2015. PMID: 26092622
-
Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.Clin Gastroenterol Hepatol. 2014 Nov;12(11):1801-12.e7. doi: 10.1016/j.cgh.2014.04.026. Epub 2014 Apr 30. Clin Gastroenterol Hepatol. 2014. PMID: 24793031
-
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.Health Technol Assess. 2006 Apr;10(11):1-110. doi: 10.3310/hta10110. Health Technol Assess. 2006. PMID: 16595080
-
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.JAMA. 2009 Jun 17;301(23):2472-85. doi: 10.1001/jama.2009.853. JAMA. 2009. PMID: 19531787
-
Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.Autoimmun Rev. 2013 Mar;12(5):607-16. doi: 10.1016/j.autrev.2012.11.001. Epub 2012 Nov 30. Autoimmun Rev. 2013. PMID: 23207285
Cited by
-
Prevalence and geographical variation of Factor V Leiden in patients with cerebral venous thrombosis: A meta-analysis.PLoS One. 2018 Aug 29;13(8):e0203309. doi: 10.1371/journal.pone.0203309. eCollection 2018. PLoS One. 2018. PMID: 30157246 Free PMC article.
-
Cerebral venous sinus thrombosis after COVID-19 vaccination and congenital deficiency of coagulation factors: Is there a correlation?Hum Vaccin Immunother. 2022 Nov 30;18(6):2095166. doi: 10.1080/21645515.2022.2095166. Epub 2022 Jul 27. Hum Vaccin Immunother. 2022. PMID: 35895937 Free PMC article.
-
Prevalence of the prothrombin G20210A mutation among ischemic stroke patients.J Cardiovasc Thorac Res. 2020;12(3):227-230. doi: 10.34172/jcvtr.2020.39. Epub 2020 Sep 3. J Cardiovasc Thorac Res. 2020. PMID: 33123330 Free PMC article.
-
Prothrombin G20210A Gene Mutation-Induced Recurrent Deep Vein Thrombosis and Pulmonary Embolism: Case Report and Literature Review.J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096211058486. doi: 10.1177/23247096211058486. J Investig Med High Impact Case Rep. 2022. PMID: 35426321 Free PMC article. Review.
-
New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.Front Immunol. 2019 Apr 16;10:764. doi: 10.3389/fimmu.2019.00764. eCollection 2019. Front Immunol. 2019. PMID: 31040845 Free PMC article. Review.
References
-
- Ferro JM, Canhão P, Stam J, Bousser M-G, Barinagarrementeria F, Investigators for the I. Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35: 664–670. - PubMed
-
- Rosendaal FR, Doggen CJM, Zivelin A, Arruda VR, Aiach M, Siscovick DS, et al. Geographic Distribution of the 20210 G to A Prothrombin Variant. Thromb Haemost. Schattauer Publishers; 1998;79: 706–708. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical